checkAd
    Startseite > Aktien > Zai Lab > Nachrichten
    Zai Lab Aktie
    15,000
     
    EUR
    +2,04 %
    +0,300 EUR
    Letzter Kurs 09:33:19 Tradegate
    14,600
     
    EUR
    415 STK
    Geldkurs 15:12:01
    15,000
     
    EUR
    403 STK
    Briefkurs 15:12:01
    ISIN: US98887Q1040 · WKN: A2DX1V · SYM: 1ZL · Kaiman-Inseln

    Neueste Nachrichten

    Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024
    15.04.24 · Business Wire (engl.) · Zai Lab
    Zai Lab Statement on Executive Management Team’s Agreement on Share Activities
    11.04.24 · Business Wire (engl.) · Zai Lab
    Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs
    02.04.24 · Business Wire (engl.) · Zai Lab
    Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic...
    01.04.24 · Business Wire (engl.) · Zai Lab
    Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
    27.03.24 · Business Wire (engl.) · Zai Lab
    Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumors
    14.03.24 · Business Wire (engl.) · Zai Lab
    Zai Lab to Present Final Overall Survival (OS) Data from Phase 3 NORA Study of ZEJULA (niraparib) in Platinum-Sensitive Recurrent Ovarian Cancer (PSROC)
    06.03.24 · Business Wire (engl.) · Zai Lab
    Zai Lab Announces Participation in March Investor Conference
    06.03.24 · Business Wire (engl.) · Zai Lab
    Zai Lab Announces Full-Year 2023 Financial Results and Recent Corporate Updates
    27.02.24 · Business Wire (engl.) · Zai Lab
    Fokus Aktien mit extremen Handelsvolumen am Dienstag, den 27.02.2024
    27.02.24 · wO Chartvergleich · Danieli & C.Officine Meccaniche
    Zai Lab to Announce Full-Year 2023 Financial Results and Recent Corporate Updates on February 27, 2024
    25.01.24 · Business Wire (engl.) · Zai Lab
    Zai Lab Announces The New England Journal of Medicine Publication Demonstrating Durable Clinical Activity of Repotrectinib in Patients with Advanced ROS1 Fusion-Positive NSCLC
    10.01.24 · Business Wire (engl.) · Zai Lab